Marion Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Buy
1,681
+8
+0.5% +$1.86K 0.09% 106
2026
Q1
$409K Buy
1,673
+7
+0.4% +$1.63K 0.09% 103
2025
Q4
$367K Buy
1,666
+9
+0.5% +$1.78K 0.08% 105
2025
Q3
$307K Buy
1,657
+10
+0.6% +$1.71K 0.07% 107
2025
Q2
$252K Buy
1,647
+11
+0.7% +$1.69K 0.06% 119
2025
Q1
$271K Buy
1,636
+10
+0.6% +$1.56K 0.07% 108
2024
Q4
$235K Buy
1,626
+167
+11% +$25.9K 0.06% 119
2024
Q3
$236K Buy
+1,459
New +$232K 0.06% 118

Other funds holding JNJ

Marion Wealth Management's JNJ Position: Q2 2026 in Review

Marion Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.48% in Q2 2026, buying an estimated $1.86K and bringing the position to 1,681 shares worth $427K. The position accounts for 0.09% of the portfolio, ranked #106.

Marion Wealth Management first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Marion Wealth Management held 1,681 shares of Johnson & Johnson worth $427K as of Q2 2026.
  • Marion Wealth Management bought 8 Johnson & Johnson shares in Q2 2026, an estimated $1.86K.
  • Johnson & Johnson made up 0.09% of Marion Wealth Management's portfolio in Q2 2026, its #106 holding.
  • Marion Wealth Management first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Marion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.